François Beck, Head of the OFDT
François Beck was born in 1970. He is currently Director of the French Monitoring Centre on Drugs and Drug Addiction (OFDT).
In 2007, he became the Head of the Department of Epidemiology and Public Health at the French National Institute for Prevention and Health Education (INPES) in Paris, France.
After completing an M.S. in statistics, he obtained a Ph.D. in sociology at the Sorbonne (Université de Paris V), where he is a Researcher of the “Psychotropics, Mental Health and Society” laboratory (Cermes3 - CESAMES), which is part of the Université Paris Descartes, La Sorbonne Paris Cité, the National Center for Scientific Research (CNRS), the National Institute for Health and Medical Research (INSERM) and the School for Advanced Studies in Social Sciences (EHESS).
His research applies epistemological reflection to the quantification of health and social issues, has focused on addictive behaviours, drug-related social factors, sleep, social inequalities, and mental health, with emphasis on methodological issues, gender, risk perception, and cross-cultural comparisons.
Since 1997, he has developed and implemented general population surveys on alcohol, tobacco, and illicit drug use in France.
Drugs in Europe
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2020 European Drug Report, our annual overview of the drug situation in Europe.
Statistical Bulletin 2020
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.